MENTAL RETARDATION, AUTOSOMAL DOMINANT 17
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Here, we describe two Japanese patients with Schuurs-Hoeijmakers syndrome with a recurrent PACS1 mutation.
|
30588754 |
2019 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 17
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Here we describe the first Indian patient with Schuurs-Hoeijmakers syndrome (SHMS) with a de novo heterozygous NM_018026.3 (PACS1):c.607C>T (p.Arg203Trp) variant.
|
30690871 |
2019 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 17
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
A novel missense mutation affecting the same amino acid as the recurrent PACS1 mutation in Schuurs-Hoeijmakers syndrome.
|
28975623 |
2018 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 17
|
0.730 |
CausalMutation
|
disease |
CLINVAR |
Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy.
|
26795593 |
2016 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 17
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome.
|
23159249 |
2012 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 17
|
0.730 |
CausalMutation
|
disease |
CLINVAR |
Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome.
|
23159249 |
2012 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 17
|
0.730 |
GeneticVariation
|
disease |
CLINVAR |
Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome.
|
23159249 |
2012 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 17
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome.
|
23159249 |
2012 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 17
|
0.730 |
GermlineCausalMutation
|
disease |
ORPHANET |
Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome.
|
23159249 |
2012 |
Intellectual Disability
|
0.440 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study.
|
30712880 |
2019 |
Intellectual Disability
|
0.440 |
GeneticVariation
|
group |
BEFREE |
Schuurs-Hoeijmakers syndrome is a rare disease characterized by intellectual disability and dysmorphic facial features among various physical abnormalities due to PACS1 mutation.
|
30588754 |
2019 |
Intellectual Disability
|
0.440 |
GeneticVariation
|
group |
BEFREE |
Schuurs-Hoeijmakers syndrome (SHMS), or Autosomal Dominant Mental Retardation Syndrome type 17 (MRD17) is a rare form of intellectual disability with distinct facial features.
|
30690871 |
2019 |
Intellectual Disability
|
0.440 |
GeneticVariation
|
group |
BEFREE |
Association of the missense variant p.Arg203Trp in PACS1 as a cause of intellectual disability and seizures.
|
28111752 |
2017 |
Intellectual Disability
|
0.440 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome.
|
23159249 |
2012 |
Intellectual Disability
|
0.440 |
GeneticVariation
|
group |
BEFREE |
Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome.
|
23159249 |
2012 |
Intellectual Disability
|
0.440 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Intellectual Disability
|
0.440 |
Biomarker
|
group |
HPO |
|
|
|
Obesity
|
0.410 |
GeneticVariation
|
disease |
BEFREE |
The pooled odds ratios of the A-allele of rs564343 in PACS1 for obesity and severe obesity were 1.180 (p = 0.03) and 1.312 (p = 0.004), respectively.
|
28564656 |
2017 |
Obesity
|
0.410 |
GeneticVariation
|
disease |
GWASCAT |
Evaluation of 29 SNPs (P < 1 × 10(-5)) in an additional 971 severely obese children and 1,990 controls identified 4 new loci associated with severe obesity (LEPR, PRKCH, PACS1 and RMST).
|
23563609 |
2013 |
Obesity
|
0.410 |
Biomarker
|
disease |
CTD_human |
Evaluation of 29 SNPs (P < 1 × 10(-5)) in an additional 971 severely obese children and 1,990 controls identified 4 new loci associated with severe obesity (LEPR, PRKCH, PACS1 and RMST).
|
23563609 |
2013 |
Obesity
|
0.410 |
GeneticVariation
|
disease |
GWASDB |
Evaluation of 29 SNPs (P < 1 × 10(-5)) in an additional 971 severely obese children and 1,990 controls identified 4 new loci associated with severe obesity (LEPR, PRKCH, PACS1 and RMST).
|
23563609 |
2013 |
Bipolar Disorder
|
0.400 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies 30 loci associated with bipolar disorder.
|
31043756 |
2019 |
Bipolar Disorder
|
0.400 |
Biomarker
|
disease |
CTD_human |
Genome-wide association study identifies 30 loci associated with bipolar disorder.
|
31043756 |
2019 |
Depression, Bipolar
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-wide association study identifies 30 loci associated with bipolar disorder.
|
31043756 |
2019 |
Manic Disorder
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-wide association study identifies 30 loci associated with bipolar disorder.
|
31043756 |
2019 |